Lates News
Canadian pharmaceutical company Lexaria Bioscience fell by 27.4% in early trading, after the company announced the termination of a $5 million stock sales agreement with JonesTrading. This decision reflects the company's strategic adjustment to optimize its capital structure and market positioning.
Latest